The global 3D printing healthcare market is projected to be worth USD 4,070.8 Million by 2027, according to a current analysis by Emergen Research. The 3D printing healthcare market is observing high demand attributed to the reduced waste generation during the production of medical devices and implants. 3D printing in healthcare is considered a sustainable production method primarily owing to its ability to reduce waste generation and being energy-efficient significantly. 3D printing uses only the required amount of material to add layer by layer to produce printed structures ensuring wastage of material to a minimum. Customized 3D-printed anatomical models specific to patients are becoming progressively beneficial tools in offering personalized treatments and precision medicine.
The detailed market intelligence report on the 3D printing healthcare market applies the best of both primary and secondary research to weighs upon the competitive landscape and the prominent market players expected to dominate the 3D printing healthcare market for the forecast period, 2020 – 2027. The study not only scans through the company profile of the major vendors but also analyses their winning strategies to give business owners, stakeholders and field marketing personnel a competitive edge over others operating in the same space. A detailed evaluation of the major events such as acquisition and mergers, collaborations, product launches, new entrants, and technology advancements offer a complete overview of what the future of the 3D printing healthcare market will be like in the years to come.
Read more@ https://www.emergenresearch.com/industry-report/3d-printing-healthcare-market
Key Highlights From The Report
In April 2020, Stratasys, Inc. entered into a collaborative agreement with Origin for the marketing and promotion of 3D-printed nasopharyngeal swabs by Origin to healthcare providers in the US to cater to the urgent need for COVID-19 testing.
Polyamide powder materials are likely to witness significant growth in the forecast period for medical devices’ production, owing to its robustness, abrasion-resistant, and improved durability.
Metal & plastic filament held a significant market share in 2019. ABS filament is a commonly used plastic in 3D printing healthcare and is very durable. It finds widespread usage in rapid prototyping and 3D printing settings for testing the impact resistance and durability of the products.
The 3D printing healthcare market in North America contributed to the largest share in share in 2019 due to rapid advancements in 3D printing technology in healthcare, increased investments in R&D, and various strategic agreements between research institutes and biotechnology firms, and increased healthcare spending, among others.
Key participants include Stratasys Inc., 3D Matters Pte Ltd., Materialise NV, Organovo, Bio3D Technologies Pte Ltd., 3D Systems Corporation, Bio-Rad Laboratories, Simbionix, EnvisionTEC, and Metamason, among others.
Request For Free Sample@ https://www.emergenresearch.com/request-sample/358
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us: Eric Lee
Web: https://www.emergenresearch.com
E-mail: sales@emergenresearch.com